Zusammenfassung
Der vorliegende Artikel zeigt aktuelle Arbeiten und Ergebnisse von Projekten im uroonkologischen Bereich am Kantonsspital St. Gallen. Einerseits wird die Immuntherapie des hormonrefraktären Prostatakarzinoms mittels dendritischer Zellvakzinierung aufgezeigt. Auf der anderen Seite stellen wir aktuelle Arbeiten aus Labor und Klinik zum nicht muskelinvasiven Urothelkarzinom der Blase vor.
Abstract
This report presents current work and results of projects in the uro-oncological field from the Cantonal Hospital of St. Gallen. The first part deals with dendritic cell-based immunotherapy of hormone refractory prostate cancer. In the second part, some recent results of clinical and laboratory work for non-muscle invasive bladder cancer are highlighted.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Prikler L, Scandella E, Men Y et al. (2004) Adaptive Immuntherapie des fortgeschrittenen Prostatakarzioms – Cancer Testis Antigene (CTA) als mögliche Zielantigene. Aktuel Urol 35: 326–330
Small EJ, Schellhammer PF, Higano CS et al. (2006) Placebo-controlled phase III trial of immunologic therapy with sipoleucel-T (APC8015) in pateints with metastatic, asymptomatic hormone-refreactory prostate cancer. J Clin Oncol 24: 3089–3094
Waekerle-Men Y, Uetz-von Allmen E, Fopp M et al. (2006) Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma. Cancer Immunol Immunother 55: 1524–1533
Sylvester R, Oosterlink W, Meijden A van der (2004) A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171: 2186–2190
Engeler DS, Wyler S, Neyer M et al. (2008) Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder – a prospective evaluation in a consecutive series of 210 cases. Scand J Urol Nephrol (in press)
Engeler DS, Scandella E, Schmid HP, Ludewig B (2006) In vitro Study of epirubicin and ciprofloxacin induced apoptosis in human urothelial cancer cell lines. Eur Urol 5(Suppl): 113
Engeler DS, Zecha H, Schmid HP (2008) Case-control study of independent metachronous malignancies in non-muscle invasive bladder cancer patients: Eur Urol 7(Suppl): 180
Interessenskonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Engeler, D., Ludewig, B. & Schmid, HP. Uroonkologische Forschung aus Labor und Klinik. Urologe 47, 978–981 (2008). https://doi.org/10.1007/s00120-008-1779-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-008-1779-1